Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321282 · ClinicalTrials.gov registry record · Phase 2
A Retrospective Analysis of the Predictive Potential of Pre-operative
A Phase 2 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 600
- Enrollment target
NCT00321282 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 600 participants.
The verdict
NCT00321282, a Phase 2 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 600 participants
- Enrollment target
Study Summary
Roughly thirty percent of people that undergo open heart surgery get an abnormal heart beat afterwards known as atrial fibrillation (AF). While not life threatening, this abnormal heart beat increases the likelihood of stroke and delays recovery. There are strategies to prevent post-operative AF, but they are costly and sometimes have undesirable side effects. Therefore, it would be best if we use these preventive treatments only in high risk patients. We intend to develop a risk prediction model based on demographic and electrocardiogram (ECG) findings that will predicted who is likely to get AF. We will develop this model using data already available on patients who have undergone cardiac surgery. The development of this model will use the latest mathematical algorithms similar to those used to study genetic evolution. This type of model is capable of looking at many parameters in an unbiased way, so that only the strongest, independent predictors remain in the final model. Once, the model is developed, we will validate the model by comparing our predictions to actual outcomes previously recorded in the database.
Interventions
- PROCEDURE Atrial Fibrillation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321282
The ClinicalTrials.gov registry entry for NCT00321282 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atrial Fibrillation is the first listed.
NCT00321282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00321282 about?
NCT00321282 is a clinical study titled "A Retrospective Analysis of the Predictive Potential of Pre-operative". Roughly thirty percent of people that undergo open heart surgery get an abnormal heart beat afterwards known as atrial fibrillation (AF). While not life threatening, this abnormal heart beat increases the likelihood of stroke and delays recovery. There are strategies to prevent post-operative AF, bu...
What is the current status of trial NCT00321282?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 600 participants. The study started on 2006-02. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00321282?
The interventions under investigation include: Atrial Fibrillation (PROCEDURE).
Who is sponsoring clinical trial NCT00321282?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.